MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. BKD
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Brookdale Senior Living (BKD) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Brookdale Senior Living
NYSE•Healthcare•Medical Care Facilities
$11.67-0.18(-0.02%)Pre-market
Market Cap
$2.77B
P/S
0.9x

Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It manages communities on behalf of others. The company was incorporated in 2005 and is headquartered in Brentwood, Tennessee.

D

How this company scores

WeakMetricSide Score: 49/100

Grade capped at D — Negative equity — the balance sheet is insolvent. Strongest: Profitability (17/25); weakest: Balance Sheet & Red Flags (8/25).

Profitability17/25
Growth9/25
Balance Sheet & Red Flags8/25
Cash & Earnings Quality15/25
Strengths
Rising free cash flowLong cash runwayProfit converts from growthImproving margins
Grade capped at D
  • Negative equity — the balance sheet is insolvent.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/S · 0.9x5y range 0.2x – 1.0x
P/S 0.9x · above its 20-quarter median

Currently above its 20-quarter median.

P/B · 15.5x5y range 0.9x – 15.5x
P/B 15.5x · above its 16-quarter median

Currently above its 16-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

Free cash flow has been negative in 4 of the last 8 quarters — earnings are not translating to cash.

Price & Volume
Market Cap $2.77B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue
$3.05B
3Q
Q. Revenue
$718.58M
12%
TTM EBITDA
$436.94M
3Q
TTM Op. Income
$106.04M
3Q
Q. Op. Income
$85.25M
3Q
TTM Net Income
$-138.31M
3Q
Q. Net Income
$23.27M
3Q
EPS
$0.1
3Q
Shares Out.
$239.13M
7Q
$3.05B in TTM revenue declined 4.4% YoY, reaching $718.58M last quarter. TTM EBITDA of $436.94M and TTM operating income of $106.04M show growth is flowing through to the bottom line. However, net income is negative at $138.31M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has fallen for 3 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin
28.6%
2Q
EBITDA Margin
21.8%
3Q
Op. Margin
11.9%
3Q
Net Margin
3.2%
3Q
Op. margin of 11.9% is up 10.0% YoY — cost efficiency is improving. Net margin at 3.2% and gross margin of 28.6% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 3 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio
N/A
P/S Ratio
0.9x
77%
P/B Ratio
N/A
3Q
P/S of 0.9x and P/B of 0.0x. P/S is low relative to typical market levels.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets
$5.90B
4%
Cash
$370.39M
47%
Long-Term Debt
$4.20B
1%
Book Value
$-28.98M
127%
D/E Ratio
N/A
3Q
Debt/EBITDA
26.9
3Q

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$91.92M
10%
TTM Free Cash Flow
$23.73M
39%
FCF Margin
0.8%
46%
FCF / Net Income
-0.2
144%
TTM FCF of $23.73M on $91.92M in operating cash flow. The FCF / Net Income ratio of -0.2x means the business consumes cash — it is not yet self-funding. Over the past year, free cash flow is up 39% — an improving trend.

Related Stocks in Healthcare

View Sector
LLY$938.28B
Lilly (Eli)
Drug Manufacturers - General
JNJ$586.47B
Johnson & Johnson
Drug Manufacturers - General
ABBV$411.57B
AbbVie
Drug Manufacturers - General
MRK$303.29B
Merck & Co.
Drug Manufacturers - General
UNH$249.74B
UnitedHealth Group
Healthcare Plans
TMO$203.77B
Thermo Fisher Scientific
Diagnostics & Research
AMGN$201.34B
Amgen
Drug Manufacturers - General
GILD$191.61B
Gilead Sciences
Drug Manufacturers - General

Leverage Risk

Red Flag

D/E ratio is 40.2 — heavily leveraged and vulnerable to rising rates or cash flow dips.

Cash Burn

Watch

4 of the last 8 quarters had negative FCF — inconsistent cash generation raises sustainability concerns.

Share Dilution

Watch

Shares outstanding rose 4.8% — mild dilution. Compare to earnings growth to assess the net per-share impact.